ReviewPharmaceuticals (Basel, Switzerland)2023

Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance.

Maria Daniela Santi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.